Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.

Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, Collin P, Green PHR, Crowe SE, Tsuji W, Butz E, Cerf-Bensussan N, Macintyre E, Parnes JR, Leon F, Hermine O, Mulder CJ; RCD-II Study Group Investigators.

Lancet Gastroenterol Hepatol. 2019 Dec;4(12):960-970. doi: 10.1016/S2468-1253(19)30265-1. Epub 2019 Sep 4.

PMID:
31494097
2.

Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma.

van Gils T, Nijeboer P, Overbeek LI, Hauptmann M, Castelijn DA, Bouma G, Mulder CJ, van Leeuwen FE, de Jong D.

United European Gastroenterol J. 2018 Dec;6(10):1485-1495. doi: 10.1177/2050640618800540. Epub 2018 Sep 12.

3.

NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.

Cheminant M, Bruneau J, Malamut G, Sibon D, Guegan N, van Gils T, Cording S, Trinquand A, Verkarre V, Lhermitte L, Brousse N, Jannot AS, Khater S, Frenzel L, Delarue R, Suarez F, Marçais A, Mulder CJ, Macintyre E, Asnafi V, Pouyet L, Bonnafous C, Lhospice F, Molina TJ, Meresse B, Cellier C, Cerf-Bensussan N, Hermine O; CELAC network°.

Gut. 2019 Aug;68(8):1396-1405. doi: 10.1136/gutjnl-2018-317371. Epub 2018 Nov 17.

PMID:
30448772
4.

The daily practice of (suspected) coeliac disease management by general practitioners: A qualitative approach.

van Gils T, Senler TG, van der Horst HE, Mulder CJJ, Bouma G, de Vries H.

Eur J Gen Pract. 2018 Dec;24(1):236-242. doi: 10.1080/13814788.2018.1516203.

5.

Gamma-Delta T Lymphocytes in the Diagnostic Approach of Coeliac Disease.

Nijeboer P, van Gils T, Reijm M, Ooijevaar R, Lissenberg-Witte BI, Bontkes HJ, Mulder CJJ, Bouma G.

J Clin Gastroenterol. 2019 May/Jun;53(5):e208-e213. doi: 10.1097/MCG.0000000000001060.

PMID:
29782465
6.

Self-reported oral health and xerostomia in adult patients with celiac disease versus a comparison group.

van Gils T, Bouma G, Bontkes HJ, Mulder CJJ, Brand HS.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Aug;124(2):152-156. doi: 10.1016/j.oooo.2017.05.475. Epub 2017 May 23.

PMID:
28756881
7.

Splenic volume differentiates complicated and non-complicated celiac disease.

van Gils T, Nijeboer P, van Waesberghe JHT, Coupé VM, Janssen K, Zegers JA, Nurmohamed SA, Kraal G, Jiskoot SC, Bouma G, Mulder CJ.

United European Gastroenterol J. 2017 Apr;5(3):374-379. doi: 10.1177/2050640616663571. Epub 2016 Aug 17.

8.

Reply.

van Gils T, Rootsaert B, Bouma G, Mulder CJ.

J Gastrointestin Liver Dis. 2017 Mar;26(1):93. doi: 10.15403/jgld.2014.1121.261.gil. No abstract available.

9.

CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.

Kooy-Winkelaar YM, Bouwer D, Janssen GM, Thompson A, Brugman MH, Schmitz F, de Ru AH, van Gils T, Bouma G, van Rood JJ, van Veelen PA, Mearin ML, Mulder CJ, Koning F, van Bergen J.

Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E980-E989. doi: 10.1073/pnas.1620036114. Epub 2017 Jan 3.

10.

Celiac Disease in The Netherlands: Demographic Data of Members of the Dutch Celiac Society.

van Gils T, Rootsaert B, Bouma G, Mulder CJ.

J Gastrointestin Liver Dis. 2016 Dec;25(4):441-445. doi: 10.15403/jgld.2014.1121.254.gil.

11.

Prevalence and Characterization of Self-Reported Gluten Sensitivity in The Netherlands.

van Gils T, Nijeboer P, IJssennagger CE, Sanders DS, Mulder CJ, Bouma G.

Nutrients. 2016 Nov 8;8(11). pii: E714.

12.

Serendipity in Refractory Celiac Disease: Full Recovery of Duodenal Villi and Clinical Symptoms after Fecal Microbiota Transfer.

van Beurden YH, van Gils T, van Gils NA, Kassam Z, Mulder CJ, Aparicio-Pagés N.

J Gastrointestin Liver Dis. 2016 Sep;25(3):385-8. doi: 10.15403/jgld.2014.1121.253.cel.

13.

The first cases of collagenous sprue successfully treated with thioguanine.

van Gils T, van de Donk T, Bouma G, van Delft F, Neefjes-Borst EA, Mulder CJ.

BMJ Open Gastroenterol. 2016 Jun 27;3(1):e000099. doi: 10.1136/bmjgast-2016-000099. eCollection 2016.

14.

Mechanisms and management of refractory coeliac disease.

van Gils T, Nijeboer P, van Wanrooij RL, Bouma G, Mulder CJ.

Nat Rev Gastroenterol Hepatol. 2015 Oct;12(10):572-9. doi: 10.1038/nrgastro.2015.155. Epub 2015 Sep 8. Review.

PMID:
26347156

Supplemental Content

Loading ...
Support Center